Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: A possible role for lysophosphatidylcholine

Atherosclerosis

Volumn 179, Issue 1, 2005, Pages 69-77

  Rosenblat, Mira ^a   Vaya, Jacob ^b   Shih, Diana ^c   Aviram, Michael ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b MIGAL GALILEE TECHNOLOGY CENTER   (Israel)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cholesterol efflux; HDL; Lysophosphatidylcholine; Macrophages; Paraoxonase

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL; CYCLIC AMP DERIVATIVE; ENZYME INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LYSOPHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2; PHOSPHOLIPID; SCAVENGER RECEPTOR BI;

ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ARTICLE; ATHEROSCLEROSIS; ATTENUATION; BINDING AFFINITY; CELL LINE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; INCUBATION TIME; KNOCKOUT MOUSE; MACROPHAGE; MACROPHAGE FUNCTION; MOUSE; MOUSE STRAIN; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RABBIT; RECEPTOR AFFINITY; RECEPTOR BLOCKING; TRANSGENIC MOUSE; WILD TYPE;

EID: 13844256208     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.10.028     Document Type: Article

References (44)

1. B.N. La Due Structural and functional diversity of paraoxonases Nat Med 2 1996 1186 1187
2. M. Aviram Does paraoxonase play a role in susceptibility to cardiovascular disease? Mol. Med. 5 1999 381 386
3. B. Mackness, P. Durrington, and P. McElduff Low paraoxonase activity predicts coronary events in the caerphilly prospective study Circulation 107 2003 2775 2779
4. D.M. Shih, L. Gu, and Y.-R. Xia Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis Nature 394 1998
5. D.M. Shih, Y.R. Xia, and E. Miller Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis J Biol Chem 275 2000 17527 17535
6. O. Rozenberg, M. Rosenblat, R. Coleman, D.M. Shih, and M. Aviram Paraoxonase (PON1) is associated with increased macrophage oxidative stress: studies in PON1-knockout mice Free Radic Biol Med 34 2003 774 784
7. A. Tward, Y.R. Xia, and X.P. Wang Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice Circulation 106 2002 484 490
8. M.N. Oda, J.K. Bielicki, and T.T. Ho Paraoxonase 1 overexpression in mice and its effect on high-density lipoproteins Biochem Biophys Res Commun 290 2002 921 927
9. Z. Ahmed, A. Ravandi, and G.F. Maguire Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (pon-1) during high density lipoprotein oxidation with a peroxynitrite donor J Biol Chem 276 2001 24473 24481
10. M. Aviram, M. Rosenblat, and C.L. Bisgaier Paraoxonase inhibits high density lipoprotein (HDL) oxidation and preserves its functions: a possible peroxidative role for paraoxonase J Clin Invest 101 1998 1581 1590
11. M. Aviram, S. Billecke, and R. Sorenson Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities. Selective action of human paraoxonase allozymes Q and R Arterioscler Thromb Vasc Biol 18 1998 1617 1624
12. M. Navab, J.A. Berliner, and A.D. Watson The yin and yang of oxidation in the development of the fatty streak: a review based on the 1004 George Lyman Duff Memorial Lecture Arterioscler Thromb Vasc Biol 16 1996 831 842
13. M. Aviram, E. Hardak, and J. Vaya Human serum paraoxonases (PON1), Q and R selectively decrease lipid peroxides in coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities Circulation 101 2000 2510 2517
14. B. Fuhrman, N. Volkova, and M. Aviram Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from atherosclerotic mice: protective role of antioxidants and paraoxonase Atherosclerosis 161 2002 307 316
15. A.J. Lusis Atherosclerosis Nature 404 2000 233 241
16. 2-like activity and lysophosphatidylcholine formation Arterioscler Thromb Vasc Biol 23 2003 461 467
17. T.S. Mikkola, M.S. Anthony, T.B. Clarkson, and R.W. Clair St. Serum cholesterol efflux potential is an independent predictor of coronary artery atherosclerosis Atherosclerosis 170 2003 31 38
18. D. Sviridov, and P. Nestel Dynamics of reverse cholesterol transport: protection against atherosclerosis Atherosclerosis 161 2002 245 254
19. A.R. Tall, P. Costet, and N. Wang Regulation and mechanisms of macrophage cholesterol efflux J Clin Invest 110 2002 899 904
20. P.G. Yancey, A.E. Bortnick, and G. Kellner-Weibel Importance of different pathways of cellular cholesterol efflux Arterioscler Thromb Vasc Biol 23 2003 712 719
21. B. Jian, M. de la Llera-Moya, and Y. Ji Scavenger receptor class B type 1 as a mediator of cellular cholesterol efflux to lipoproteins and phospholipids acceptor J Biol Chem 273 1998 5599 5606
22. O.L. Francone SR-BI, a new player in an old game Arterioscler Thromb Vasc Biol 23 2003 1486 1487
23. J.F. Oram HDL apolipoprotein and ABCA1. Partners in the removal of excess cellular cholesterol Arterioscler Thromb Vasc Biol 23 2003 720 727
24. N. Wang, and A.R. Tall Regulation and mechanism of ATP-binding cassette transporter A1-mediated cellular cholesterol efflux Arterioscler Thromb Vasc Biol 23 2003 1178 1184
25. M. Aviram Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients Biochem Med 30 1983 111 118
26. O.H. Lowry, N.J. Rosenberg, L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 265 275
27. K. Gan, A. Smolen, H.W. Eckerson, and B.N. La Du Purification of human serum paraoxonase/arylesterase: evidence for one esterase catalyzing both activities Drug Metab Dispos 19 1991 100 106
28. A. Aharoni, L. Gaidukov, L. Toker, I. Silman, and D.S. Tawfik Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization Proc Natl Acad Sci 101 2003 482 487
29. 3H] cholesterol efflux to high and low density lipoproteins is dependent on lipoprotein binding to the receptor J Biol Chem 275 2000 29993 30001
30. J.F. Oram, R.M. Lawn, M.R. Garvin, and D.P. Wade ABCA1 cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages J Biol Chem 275 2000 34508 34511
31. P. Zheng, A. Horwitz, C.A. Waelde, and J.D. Smith Stably transfected ABCA1 antisense cell line has decreased ABCA1 mRNA and cAMP-induced cholesterol efflux to apolipoprotein AI and HDL Biochem Biophys Acta 1534 2001 121 128
32. S. Billecke, D. Draganov, and R. Counsell Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters Drugs Metab Dispos 28 2000 1335 1342
33. 2 in fatty acid incorporation, phospholipids remodeling, lysophosphatidylcholine generation, and secretagogue-induced arachidonic acid release in pancreatic islets and insulinoma cells J Biol Chem 274 1999 13915 13927
34. J.D. Smith, W.L. Goff, and M. Settle ABCA1 mediated concurrent cholesterol and phospholipids efflux to apolipoprotein A-I J Lipid Res 45 2004 634 644
35. Y. Yamauchi, S. Abe-Dohmae, and S. Yokoyama Differential regulation of apolipoprotein A-I/ATP binding cassette transporter A1-mediated cholesterol and phospholipids release Biochem Biophys Acta 1585 2002 1 10
36. G. Kellner-weibel, S.J. Luke, and G.H. Rothblat Cytotoxic cellular cholesterol is selectively removed by apoA-I via ABCA1 Atherosclerosis 171 2003 235 243
37. N. Wang, D.L. Silver, P. Costet, and A.R. Tall Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABCA1 J Biol Chem 275 2000 33053 33058
38. M.L. Fitzgerald, A.L. Morris, and J.S. Rhee Naturally occurring mutations in the largest extracellular loops of ABCA1 can disrupt its direct interaction with apolipoprotein A-I J Biol Chem 277 2002 33178 33187
39. Y. Yamauchi, M. Hayashi, S. Abe-Dohmae, and S. Yokoyamas Apolipoprotein A-I activates protein kinase Cα signaling to phosphorylate and stabilize ATP binding cassette transporter A1 for high density lipoprotein assembly J Biol Chem 278 2003 47890 47897
40. B. Haidar, M. Denis, M. Marcil, L. Krimbou, and J. Genest Jr. Apolipoprotein A-I activates cellular cAMP signaling through the ABCA1 transporter J Biol Chem 279 2004 9963 9999
41. B. Haidar, M. Denis, L. Krimbou, M. Marcil, and J. Genest Jr. cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts J Lipid Res 43 2002 2087 2094
42. O. Chambenoit, Y. Hamon, and D. Marguet Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1 transporter J Biol Chem 276 2001 9955 9960
43. S. Hara, T. Shike, N. Takasu, and T. Mizui Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells Arterioscler Thromb Vasc Biol 17 1997 1258 1266
44. R.C. Sorenson, C.L. Bisgaier, and M. Aviram Human serum paraoxonase/arylesterase retained hydrophobic N-terminal leader sequence associated with HDLs by binding phospholipids: apolipoprotein A-I stabilizes activity Arterioscler Thromb Vasc Biol 19 1999 2214 2225